Rocky Mountain Cancer Centers-Boulder — Boulder, Colorado

Rocky Mountain Cancer Centers-Boulder is a clinical research site located in Boulder, Colorado, United States 80304.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers-Boulder has participated in 205 clinical trials with 131 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers-Boulder?

Rocky Mountain Cancer Centers-Boulder has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers-Boulder conducted?

Rocky Mountain Cancer Centers-Boulder has 205 clinical trials on record, with 131 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Is Rocky Mountain Cancer Centers-Boulder accredited by Crixeo Health?

Rocky Mountain Cancer Centers-Boulder has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers-Boulder?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.